期刊文献+

免疫质谱技术及其临床研究应用进展

Advances in immune mass spectrometry and its clinical application
原文传递
导出
摘要 免疫质谱技术是新近发展起来的联合抗体分离技术与生物质谱技术的一种分析技术,除具有传统的放射免疫技术、酶免疫技术和荧光免疫技术的高特异、高灵敏和质谱技术的高通量特点外,还具有分辨修饰和变异的高度精确性。在肿瘤、自身免疫病、代谢性疾病和退行性疾病等的诊断、病情监测和疗效判断等方面都将有广阔的应用前景。 Immunologic spectrometry is a newly developed technology with combination of antibody isolation and biological mass spectrometry.It has the merits including high specificity and highsensitivity that are similar to traditional radioimmunoassay,enzyme immunoassay and fluorescence immunity technology.It is also a high-throughput technology that is simitar to mass spectrometry.Immuologic mass spectrometry also posesses highle accuracy and resotation for modification and variation.It will have a broad application in tumor,autoimmune diseases,metabolic diseases and degenerative diseases diagnosis,disease monitoring and curative efficact judgments,etc.
作者 程琳琳 李永哲 Cheng Linlin;Li Yongzhe(Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China)
出处 《中华临床实验室管理电子杂志》 2017年第4期200-211,共12页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
基金 国家自然科学基金项目(81671618 81373188) 国家重点研发计划资助课题(2016YFC0903900) 首都卫生发展科研专项资助课题(2014-1-4011) 中国医学科学院医学与健康科技创新工程项目资助课题(2017-12M-3-001)
关键词 免疫质谱技术 自身免疫病 肿瘤 代谢性疾病 退行性疾病 蛋白质组学 Immunologic mass spectrometry Autoimmune diseases Tumors Metabolic diseases Degenerative diseases Proteomics
  • 相关文献

参考文献1

二级参考文献10

  • 1Ikeda S, Wong CW, Allsop D, et al. Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheime's disease with an anti-beta protein monoclonal antibody[J]. Lab Invest, 1987, 57(4) :446-449.
  • 2Terai K, Iwai A, Kawabata S, et al. Beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease[ J]. Neuro sci- ence, 2001, 104(2) :299-310.
  • 3Fung ET, Yip TT, Lomas L, et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays [J]. Int J Cancer, 2005, 115(5) : 783-789.
  • 4Schweigert FJ, Wirth K, Raila J. Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay[ J], Proteome Sci, 2004, 2( 1 ) :5.
  • 5Bleijlevens B, van Breemen MJ, Donker-Koopman WE, et al. Detection of mutant protein in complex biological samples: glueocerebrosidase mutations in Gaucher's disease[ J ]. Anal Biochem, 2008, 372( 1 ):52-61.
  • 6Peronnet E, Becqaart L, Poirier F, et al. SELDI-TOF MS analysis of the cardiac troponin I forms present in plasma from patients with myocardial infarction [ J ]. Proteomics, 2006, 6 (23) :6288-6299.
  • 7Bovenkamp DE, Stanley BA, Van Eyk JE. Optimization of cardiac troponin Ⅰ pull-down by IDM affinity beads and SELDI[ J]. Methods Mol Biol, 2007, 357:91-102.
  • 8Gregson BP, Millie DF, Cao C, et al. Simplified enrichment and identification of environmental peptide toxins using antibody-capture surfaces with subsequent mass spectrometry detection[ J]. J Chromatogr A, 2006, 1123(2) :233-238.
  • 9Whiteaker JR, Zhao L, Zhang HY, et al. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers [ J ]. Anal Biochem, 2007, 362( 1 ) :44-54.
  • 10胡朝军,李永哲.蛋白质指纹图谱技术在疾病研究中的应用[J].临床检验杂志,2008,26(3):227-229. 被引量:11

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部